ADMA Biologics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Thank you, everyone, for joining us today. I'm Drew Ranieri, a medical device analyst here at Morgan Stanley. It's my pleasure to have Adam Grossman, President and CEO; and Brian Lenz, EVP and CFO, from ADMA Biologics today.
Before we jump into Q&A, I just have to get the disclaimer out of the way first. But for important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
With that out of the way, Adam, Brian, thanks so much for being with us today, looking forward to the conversation.
Questions & Answers
And really as an observer of the company, it looks like there's been a tremendous amount of progress on both the commercial side and operationally over the last 12 months. So you've essentially spent kind of the last
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
